All Videos

An expert rheumatologist and dermatologist discuss differences between biosimilars and generic drugs.

In this week’s Pointers with Dr Portela, the 208SkinDoc discusses the 5 biggest cleansing mistakes.

Drs Noor and Bhatia have a conversation about cost and financial assistance from pharmaceutical companies.

Drs Bhatia and Lamb discuss the case of a 12-year-old child with asthma and how they would manage his disease.

Experts treating pediatric atopic dermatitis discuss the pharmacological options for the treatment of pediatric atopic dermatitis.

Expert pediatric dermatologists Elizabeth Swanson, MD, and Joshua Zeichner, MD, discuss the burden of pediatric atopic dermatitis.

Brittany Craiglow, MD; Raj Chovatiya, MD, PhD; and Joshua Zeichner, MD, discuss the presentation of pediatric patients with atopic dermatitis and how to properly assess and diagnose pediatric patients’ atopic dermatitis.

Elizabeth Swanson, MD, and Joshua Zeichner, MD, discuss the psychological factors impacting pediatric patients’ atopic dermatitis.

Joshua Zeichner, MD, and Raj Chovatiya, MD, PhD, dive deep into the pathogenesis of atopic dermatitis and discuss how agents treating atopic dermatitis work.

Joshua Zeichner, MD, and Vikash Oza, MD, discuss characteristics of type 2 inflammation and the impact of itching on pediatric patients with atopic dermatitis.

In this week’s Pointers with Dr Portela, the 208SkinDoc interviews Josh Zeichner, MD, and discusses Jori Skincare.

Experts discuss the case of a 4-year-old girl with lighter skin and treatment options for a young child.

Three experts emphasize the importance of setting expectations for AD treatment with patients.

Susan Taylor, MD, FAAD, discusses how an individual can select a sunscreen as well as barriers to using them.

Dr Susan Taylor, an expert dermatologist, discusses how to increase awareness and avoid misconceptions for individuals using sunscreens.

Susan Taylor, MD, FAAD, discusses how to select a sunscreen based on different patient characteristics.

In this week’s Pointers with Dr Portela, the 208SkinDoc travels to the La Roche-Posay Thermal Treatment Center.

Drs Noor and Lamb discuss mechanisms of action of biologics and JAK inhibitors and the importance of patient communication while selecting AD treatments.

Drs Lamb, Noor, and Bhatia discuss their approach to selecting treatment in light of recent AD approvals.

Drs Roy M. Fleischmann and Joel M. Gelfand discuss differences between biosimilars and reference products.

Roy M. Fleischmann, MD and Joel M. Gelfand, MD, MSCE, FAAD define the terms biologic and biosimilars and discuss how they are developed.

Expert dermatologist, Susan Taylor, MD, FAAD, discusses available sunscreen options to patients.

Susan Taylor, MD, FAAD, discusses FDA regulations for sunscreens.

In this week’s Pointers with Dr Portela, the 208SkinDoc talks about how to improve wrinkles fast.

Drs Noor and Lamb highlight the importance of frank discussion of adverse effects of atopic dermatitis treatments with patients.

Drs Bhatia, Lamb and Noor talk about the importance of building trust with patients and highlight topics to discuss with patients and parents.

Susan Taylor, MD, FAAD, addresses gaps in understanding damage to the skin by the general population.

Expert dermatologist Susan Taylor, MD, FAAD, provides education to community dermatologists about the pathophysiology of skin damage

Pearl Grimes, MD, FAAD, and director of the Grimes Center of Medical and Aesthetic Dermatology and the Vitiligo & Pigmentation Institute of Southern California in Los Angeles, explains why the FDA approval of ruxolitinib cream 1.5% is monumental in the treatment of vitiligo.

Results published in the Journal of the American Medical Association (JAMA) Dermatology detailed the efficacy and safety of berdazimer gel 10.3%, in the treatment of molluscum contagiosum.